Skip to main content
. 2022 May 1;61(3):305–312. doi: 10.1590/2359-3997000000274

Table 4. Familial forms of primary aldosteronism.

  Type I Type III Type III
Cause Hybrid CYP11B1/CYP11B2 Unknown Germline KCNJ5
Transmission Autosomal dominant Autosomal dominant Autosomal dominant
Genetic diagnosis Long PCR No KCNJ5 sequencing
Hypertension onset Very often < 20 years Adulthood Very often < 10 years
Hypertension severity Severe to resistant hypertension (normal BP is rare) Stage 1 to resistant hypertension (normal BP is not often) Stage 3 to resistant hypertension
Hypokalemia Rare Not often Very often
Aldosterone after dexamethasone < 4 ng/dL > 4 ng/dL > 4 ng/dL
Adrenal CT Normal Unilateral or bilateral lesions Bilateral macronodular hyperplasia
Treatment Dexamethasone or mineralocorticoid antagonist Unilateral adrenalectomy or mineralocorticoid antagonist Bilateral adrenalectomy or mineralocorticoid antagonist

BP: blood pressure. CT: computed tomography.